nach oben

Erschienen in:

12.01.2022 | Original Paper

User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation

verfasst von: Sabrina Darrow, Morgan Pelot, Sarah Naeger, Laysha Ostrow

Erschienen in: Community Mental Health Journal | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Psychiatric medication discontinuation is common and can have negative impacts. Until recently, most research on discontinuation happened in an adherence/compliance framework. There is now recognition that discontinuation may be a desired goal for many individuals. The purpose of the present paper is to describe the results of a pioneering survey to explore professional support to service users during medication discontinuation to inform clinical practice and guide future research. Survey responses from 250 service users were summarized with regard to their use of prescriber and psychotherapy services during the process of discontinuing psychiatric medication. Only 65% of respondents reported seeing a prescriber and less than 50% reported seeing a psychotherapist while attempting to discontinue psychiatric medication. Combined with respondents’ answers describing the decision-making process and support received from these services, this paper identifies gaps in service and the need to improve providers’ ability to support individuals while they discontinue psychiatric medication.

Carey, B. & Gebeloff, B. (2018). Many people taking antidepressants discover they cannot quit. The New York Times. http://www.nytimes.com

Chouinard, G., & Chouinard, V. A. (2008). Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychotherapy and Psychosomatics, 77(2), 69–77. https://doi.org/10.1159/000112883CrossRefPubMed

Cohen, D., & Recalt, A. M. (2019). Discontinuing psychotropic drugs from participants in randomized controlled trials: A systematic review. Psychotherapy and Psychosomatics, 88(2), 96–104.CrossRef

Dixon, L. B., Holoshitz, Y., & Nossel, I. (2016). Treatment engagement of individuals experiencing mental illness: Review and update. World Psychiatry, 15(1), 13–20.CrossRef

Easter, A., Pollock, M., Pope, L. G., Wisdom, J. P., & Smith, T. E. (2015). Perspectives of treatment providers and clients with serious mental illness regarding effective therapeutic relationships. The Journal of Behavioral Health Services & Research, 43(3), 341–353. https://doi.org/10.1007/s11414-015-9492-5CrossRef

El-Mallakh, P., & Findlay, J. (2015). Strategies to improve medication adherence in patients with schizophrenia: The role of support services. Neuropsychiatric Disease and Treatment, 11, 1077–1090. https://doi.org/10.2147/NDT.S56107CrossRefPubMedPubMedCentral

Fava, G. A. (2003). Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 64, 123–133.CrossRef

Gibson, K., Cartwright, C., & Read, J. (2014). Patient-centered perspectives on antidepressant use. International Journal of Mental Health, 43(1), 81–99. https://doi.org/10.2753/IMH0020-7411430105CrossRef

Gibson, K., Cartwright, C., & Read, J. (2016). ‘In my life antidepressants have been…’: A qualitative analysis of users’ diverse experiences with antidepressants. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0844-3CrossRefPubMedPubMedCentral

Green, C. A., Polen, M. R., Janoff, S. L., Castleton, D. K., Wisdom, J. P., Vuckovic, N., Perrin, N. A., Paulson, R. I., & Oken, S. L. (2008). Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. Psychiatric Rehabilitation Journal, 32(1), 9–22. https://doi.org/10.2975/32.1.2008.9.22CrossRefPubMedPubMedCentral

Gupta, S., & Cahill, J. D. (2016). A prescription for “deprescribing” in psychiatry. Psychiatric Services, 67(8), 904–907.CrossRef

Hasson-Ohayon, I. (2018). Overlap and distinction between measures of insight and self-stigma. Psychiatric Research, 266, 47–64.CrossRef

Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/10.1177/1049732318793418CrossRefPubMed

Keisler-Starkey, K. & Bunch, L.N. (2020). Health insurance coverage in the United States: 2019. U.S. Census Bureau Current Population Reports, pp 60–271.

National Institute for Health and Care Excellence (NICE). (2009). Depression in adults: recognition and management. www.nice.org.uk/guidance/cg90.

Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health, 27(4), 322–328. https://doi.org/10.1080/09638237.2017.1370637CrossRefPubMed

Ostrow, L., Croft, B., Weaver, A., & Naeger, S. (2019). An exploratory analysis of the role of social supports in psychiatric medication discontinuation: Results related to family involvement. Psychosis, 11(3), 212–222.CrossRef

Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017). Discontinuing psychiatric medications: A survey of long-term users. Psychiatric Services, 68(12), 1232–1238. https://doi.org/10.1176/appi.ps.201700070CrossRefPubMed

Read, J., Cartwright, C., & Gibson, K. (2018). How many of 1829 antidepressant users report withdrawal effects or addiction? International Journal of Mental Health Nursing, 27(6), 1805–1815. https://doi.org/10.1111/inm.12488CrossRefPubMed

Read, J., & Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176–186. https://doi.org/10.2174/1574886313666180605095130CrossRefPubMed

Ride, J., Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., & Jacobs, R. (2019). Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness. Health Services Research, 54(6), 44.CrossRef

Robiner, W. N., Tompkins, T. L., & Hathaway, K. M. (2019). Prescriptive authority: Psychologists’ abridged training relative to other professions’ training. Clinical Psychology: Science and Practice, 27(1), 58.

Roe, D., & Davidson, L. (2017). Noncompliance, nonadherence, and dropout: Outmoded terms for modern recovery-oriented mental health. Psychiatric Services, 68(10), 1076–1078. https://doi.org/10.1176/appi.ps.201600522CrossRefPubMed

Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38–46. https://doi.org/10.2975/33.1.2009.38.46CrossRefPubMed

Roe, D., Jones, N., Hasson-Ohayon, I., & Zisman-Ilani, Y. (2021). Conceptualization and study of antipsychotic medication use: From adherence to pattern of use. Psychiatric Services, 00, 1–3.

Russo, J. (2018). Through the eyes of the observed: Re-directing research on psychiatric drugs. Talking Point Papers, 3.

Salyers, M. P., & Zisman-Ilani, Y. (2020). Shared decision-making and self-directed care. In H. H. Goldman, R. G. Frank, & J. P. Morrissey (Eds.), The palgrave handbook of American mental health policy (pp. 197–228). Springer International Publishing.CrossRef

Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2018). Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Systematic Reviews, 7(1), 10. https://doi.org/10.1186/s13643-018-0676-yCrossRefPubMedPubMedCentral

Slade, M. (2017). Implementing shared decision making in routine mental health care. World Psychiatry, 16(2), 146–153.CrossRef

Stanhope, V., Tondora, J., Davidson, L., Choy-Brown, M., & Marcus, S. C. (2015). Person-centered care planning and service engagement: a study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-015-0715-0CrossRefPubMedPubMedCentral

Stein, B. D., Kogan, J. N., Mihalyo, M. J., Schuster, J., Deegan, P. E., Sorbero, M. J., & Drake, R. E. (2013). Use of a computerized medication shared decision making tool in community mental health settings: Impact on psychotropic medication adherence. Community Mental Health Journal, 49(2), 185–192.CrossRef

The International Early Psychosis Association writing Group. (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(suppl. 48), s120–s124.CrossRef

Tobon, A. L., Flores, J. M., Taylor, J. H., Johnson, I., Landeros-Weisenberger, A., Aboiralor, O., Avila-Quintero, V. J., & Bloch, M. H. (2021). Racial implicit associations in psychiatric diagnosis, treatment, and compliance expectations. Academic Psychiatry, 45, 23–33.CrossRef

White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management, and raising of awareness of, antidepressant withdrawal: Is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320981174CrossRefPubMedPubMedCentral

Zisman-Ilani, Y., Barnett, E., Harik, J., Pavlo, A., & O’Connell, M. (2017). Expanding the concept of shared decision making for mental health: Systematic search and scoping review of interventions. Mental Health Review Journal, 22(3), 191–213. https://doi.org/10.1108/MHRJ-01-2017-0002CrossRef

Zisman-Ilani, Y., Lysaker, P. H., & Hasson-Ohayon, I. (2021). Shared risk taking: Shared decision making in serious mental illness. Psychiatric Services, 72(4), 461–463. https://doi.org/10.1176/appi.ps.202000156CrossRefPubMed

Zisman-Ilani, Y., Roe, D., Elwyn, G., Kupermintz, H., Patya, N., Peleg, I., & Karnieli-Miller, O. (2019). Shared decision making for psychiatric rehabilitation services before discharge from psychiatric hospitals. Health Communication, 34(6), 631–637. https://doi.org/10.1080/10410236.2018.1431018CrossRefPubMed

Zisman-Ilani, Y., Shern, D., Deegan, P., Kreyenbuhl, J., Dixon, L., Drake, R., Torrey, W., Mishra, M., Gorbenko, K., & Elwyn, G. (2018). Continue, adjust, or stop antipsychotic medication: Developing and user testing an encounter decision aid for people with first-episode and long-term psychosis. BMC Psychiatry, 18(1), 142.CrossRef

Titel: User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation
verfasst von: Sabrina Darrow
Morgan Pelot
Sarah Naeger
Laysha Ostrow
Publikationsdatum: 12.01.2022
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 7/2022
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-021-00933-3

General Beliefs About Illicit Drug Use and Stigma: Perspective of People Who Use Illicit Drugs

Original Paper

Developing a Needs Assessment Process to Address Gaps in a Local System of Care

Original Paper

Weill Cornell Medicine Wellness Qlinic: Adapting the Student-Run Clinic Model to Expand Mental Health Services and Medical Education

Fresh Focus

Employer and Co-worker Perspectives on Hiring and Working with People with Mental Health Conditions

Open Access
Original Paper

Effects on Participant Knowledge, Situational Anxiety, and Social Distance Attitudes Following CIT Training

Original Paper

Leading from the Middle: Practical Innovation in Public Mental Health

Fresh Focus

Neu im Fachgebiet Psychiatrie

Demenz-Leitlinie aktualisiert

13.03.2025
Demenz
Nachrichten

Empfohlen wird jetzt auch eine Musiktherapie sowie bei unklarem diagnostischem Befund ein Tau-PET, und Depressive mit leichten kognitiven Störungen sollten eine Verhaltenstherapie erhalten – das sind einige wichtige Änderungen der aktuellen S3-Leitlinie Demenzen.

Positive Signale für Semaglutid bei Alkoholabhängigkeit

12.03.2025
Substanzabusus und Sucht
Nachrichten

Daten einer kleinen Phase-II-Studie sprechen dafür, GLP-1-Rezeptoragonisten in der Behandlung von Alkoholabhängigkeit weiter zu untersuchen.

Wer hat Angst vorm elektromagnetischen Feld?

12.03.2025
Psychosomatik in der Hausarztpraxis
Nachrichten

Ist elektromagnetische Strahlung auch unterhalb von gesetzlichen Grenzwerten gesundheitsschädlich? Ein kleiner Teil der Ärzteschaft hält das für möglich, wobei eher an psychosomatische Effekte gedacht wird, wie eine deutsche Studie nahelegt. Das selbst eingeschätzte Wissen zum Thema ist indes gering.

Crohn und Colitis: Medikamente sind nicht alles

07.03.2025
Morbus Crohn
Kongressbericht

Chronisch-entzündliche Darmerkrankungen erfordern medizinisches Handeln auf vielen Ebenen. Schübe können durch zahlreiche Faktoren beeinflusst werden. Und vielleicht gelingt es bald sogar, einen Teil der Erkrankungsfälle zu antizipieren.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation

Abstract

Weitere Artikel der Ausgabe 7/2022

General Beliefs About Illicit Drug Use and Stigma: Perspective of People Who Use Illicit Drugs

Developing a Needs Assessment Process to Address Gaps in a Local System of Care

Weill Cornell Medicine Wellness Qlinic: Adapting the Student-Run Clinic Model to Expand Mental Health Services and Medical Education

Employer and Co-worker Perspectives on Hiring and Working with People with Mental Health Conditions

Effects on Participant Knowledge, Situational Anxiety, and Social Distance Attitudes Following CIT Training

Leading from the Middle: Practical Innovation in Public Mental Health

Neu im Fachgebiet Psychiatrie

Demenz-Leitlinie aktualisiert

Positive Signale für Semaglutid bei Alkoholabhängigkeit

Wer hat Angst vorm elektromagnetischen Feld?

Crohn und Colitis: Medikamente sind nicht alles

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten